End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
131.4 EUR | -1.07% |
|
-1.87% | +40.23% |
28/06 | India plans incentives for diabetes, obesity drug makers in 2026, government official says | RE |
28/06 | NOVO NORDISK : UBS gives a Neutral rating | ZD |
Sales 2024 * | 292B 41.91B 39.06B 3,493B | Sales 2025 * | 352B 50.65B 47.2B 4,221B | Capitalization | 4,460B 641B 597B 53,419B |
---|---|---|---|---|---|
Net income 2024 * | 104B 14.99B 13.97B 1,249B | Net income 2025 * | 128B 18.39B 17.14B 1,532B | EV / Sales 2024 * | 15.4 x |
Net Debt 2024 * | 22.58B 3.24B 3.02B 270B | Net cash position 2025 * | 5.93B 852M 794M 71.01B | EV / Sales 2025 * | 12.6 x |
P/E ratio 2024 * |
43.3
x | P/E ratio 2025 * |
35.2
x | Employees | 66,015 |
Yield 2024 * |
1.17% | Yield 2025 * |
1.44% | Free-Float | 70.22% |
Latest transcript on Novo Nordisk A/S
1 day | -1.07% | ||
1 week | -1.87% | ||
Current month | +7.70% | ||
1 month | +6.41% | ||
3 months | +8.60% | ||
6 months | +41.64% | ||
Current year | +40.23% |
![Extreme 131.40000000](/images/extremecours_fleche.png)
![Extreme 121.74](/images/extremecours_fleche.png)
![Extreme 92.6](/images/extremecours_fleche.png)
![Extreme 68.14](/images/extremecours_fleche.png)
![Extreme 34.74](/images/extremecours_fleche.png)
![Extreme 21.01](/images/extremecours_fleche.png)
![Extreme 17.9475](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 58 | 01/91/01 | |
Director of Finance/CFO | 53 | 01/99/01 | |
Stephen Gough
CTO | Chief Tech/Sci/R&D Officer | - | 01/15/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sylvie Grégoire
BRD | Director/Board Member | 62 | 19/15/19 |
Helge Lund
CHM | Chairman | 61 | 23/17/23 |
Martin MacKay
BRD | Director/Board Member | 68 | 01/18/01 |
Date | Price | Change | Volume |
---|---|---|---|
28/24/28 | 134.7 | +0.27% | 251 |
27/24/27 | 134.3 | -0.34% | 685 |
26/24/26 | 134.8 | -2.30% | 702 |
25/24/25 | 138 | +4.34% | 865 |
24/24/24 | 132.2 | -0.32% | 249 |
End-of-day quote Wiener Boerse, June 17, 2024
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+55.32% | 819B | |
-6.75% | 351B | |
+13.56% | 329B | |
+10.68% | 298B | |
+16.57% | 242B | |
+2.04% | 225B | |
+13.31% | 217B | |
+8.48% | 168B | |
-2.81% | 158B |
- Stock Market
- Equities
- NOVO B Stock
- NNO2 Stock